The Current and Future State of Healthcare

In this advanced program, learn about the growing competition between payers and providers as they seek to control the gateway to the healthcare system

$650

The Current and Future State of Healthcare

In this advanced program, learn about the growing competition between payers and providers as they seek to control the gateway to the healthcare system

$650

The Current and Future State of Healthcare

In this advanced program, learn about the growing competition between payers and providers as they seek to control the gateway to the healthcare system

$650

The Current and Future State of Healthcare

In this advanced program, learn about the growing competition between payers and providers as they seek to control the gateway to the healthcare system

$650

The Current and Future State of Healthcare

In this advanced program, learn about the growing competition between payers and providers as they seek to control the gateway to the healthcare system

$650

The Current and Future State of Healthcare

In this advanced program, learn about the growing competition between payers and providers as they seek to control the gateway to the healthcare system

$650

The Current and Future State of Healthcare

In this advanced program, learn about the growing competition between payers and providers as they seek to control the gateway to the healthcare system

$650

The Current and Future State of Healthcare

In this advanced program, learn about the growing competition between payers and providers as they seek to control the gateway to the healthcare system

The Current and Future State of Healthcare

In this advanced program, learn about the growing competition between payers and providers as they seek to control the gateway to the healthcare system

Manufacturers Restricting 340B Sales to Contract Pharmacies

  • Abbvie
  • Amgen
  • AstraZeneca
  • Boehringer Ingelheim
  • Eli Lilly
  • Merck
  • Novartis
  • Novo Nordisk
  • Sanofi
  • UCB
  • United Therapeutics
  • and more…